Narrative review / 2020
Whole-apple intake is linked to lower cardiovascular disease risk and improves multiple cardiovascular risk factors.
This narrative review evaluated evidence from 8 observational studies and 8 randomized trials on whole-apple intake and cardiovascular disease risk factors. In the observational studies, apple intake was linked to lower CVD mortality, ischemic heart disease mortality, stroke mortality, all-cause mortality, severe abdominal aortic calcification, and lower C-reactive protein. In randomized trials, consuming whole apples reduced total cholesterol, LDL cholesterol, systolic blood pressure, pulse pressure, inflammatory cytokines, and CRP, while increasing HDL cholesterol and improving endothelial function. The review concluded that consuming 100 to 150 g/day of whole apples associates with lower CVD risk and benefits various risk markers.
- Study type
- Narrative review of observational studies and randomized trials
- Who was studied
- Participants in 8 observational studies and 8 randomized trials
- What was measured
- CVD risk, mortality, lipid levels, blood pressure, inflammatory markers
THE PAPER
The effects and associations of whole-apple intake on diverse cardiovascular risk factors. A narrative review.
Sandoval-Ramírez BA, Catalán Ú, Calderón-Pérez L, Companys J, Pla-Pagà L, Ludwig IA, Romero MP, Solà R. Crit Rev Food Sci Nutr, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.